Antimicrobial activity of apramycin formulated with dextran-based single-chain polymeric nanoparticles against Acinetobacter baumannii
The global emergence of antimicrobial resistance is driving the development of novel strategies for treating bacterial infections. In this context, dextran-based single-chain polymeric nanoparticles (DXT-SCPNs) have been developed as antibiotic delivery systems for the treatment of pulmonary infections. A series of DXT-SCPNs were formulated with apramycin with different physicochemical properties, namely three degrees of substitution (with a low degree of crosslinking in all cases): low (L-DS a ), medium (M-DS a ), or high (H-DS a ), and two degrees of crosslinking (with a medium degree of substitution in both nanoparticles): low (M-DSa) or high (H-CL a ). Their in vitro activity against eleven Acinetobacter baumannii clinical isolates was assessed compared to the free drug, using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill kinetic (TKK) assays. Overall, no statistically significant differences were observed between the antimicrobial activity of free and formulated apramycin. Nevertheless, a slight trend towards higher activity was observed in the cases of M-DS a and H-CL a .
Authors
- José María Marimón (ORCID: https://orcid.org/0000-0002-2787-7094)
- Julie Movellan (ORCID: https://orcid.org/0000-0002-3645-5192)
- Iraida Loinaz (ORCID: https://orcid.org/0000-0003-0331-5801)
- Damien Dupin (ORCID: https://orcid.org/0000-0003-0868-9028)
- Jose Carlos Ibañez Ramos
Institutions
- University of the Basque Country (ES)
- Biogipuzkoa Health Research Institute (ES)
- Centre for Electrochemical Technologies (ES)
- Donostiako Unibertsitate Ospitalea (ES)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s41598-026-79821-3
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00